Integrated Cancer Research > ICR Research > Colorectal Cancer Research Consortium
Information for Patients This website has been designed to help you understand pathology reporting of Bowel Cancer Bowel Cancer generally affects the colon or rectum. For this reason it is also known as Colorectal Cancer. Bowel Cancer is the second most common cancer affecting both men and women in NSW. To find out more about the pathology reporting of Bowel Cancer please click here. To find out more general knowledge on Bowel Cancer, please click here to go to the Cancer Council NSW Website section on understanding Bowel Cancer. Page under development... Histopathology Reporting The pathology report represents a summation of the available information on the cancer. It is the single most powerful indicator used by clinicians to define prognostic risk and the need for adjuvant therapy. A minimum dataset for the reporting of colorectal cancers has been developed by the CCRC in collaboration with the Cancer Council NSW, the NSW Oncology Group for Colorectal Cancer and the Cancer Institute NSW. Read more... Histopathology Reporting Guidelines Histopathology Report Proforma Surgical Request Proforma Research The Translation of Mismatch Repair Deficiency Testing into Clinical Practice We are currently conducting a study that will look into a recent advancement in colorectal cancer biology and see how this advancement can be incorporated into common clinical practice. The study is based on the identification of mismatch repair-deficient (MMRD) colorectal cancers and how such identification can be translated into clinical practice. Read more... About Us Mission The mission of the Colorectal Cancer Research Consortium is to develop and test better systems for the identification, integration and dissemination of clinically relevant information about colorectal cancer. Goals Our primary goal is to develop conventions for the reporting of pathological features of colorectal cancers that can be uniformly applied across our Area Health and NSW. Using the examples of Mismatch Repair Deficiency (MMRD) testing, our secondary goal is to explicitly model the ways in which basic science can be translated into advances in clinical practice.